Browsing publications by Professor Graham Jackson

Newcastle AuthorsTitleYear
Dr Nicola Sunter
Professor Andy Hall
Dr Tryfonia Mainou-Fowler
Professor Graham Jackson
Dr James Allan
et al.
A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia2014
Professor Graham Jackson
Minimal Residual Disease: What Are the Minimum Requirements? Reply2014
Professor Graham Jackson
Biologically defined risk groups can be used to define the impact of thalidomide maintenance therapy in newly diagnosed multiple myeloma2013
Professor Graham Jackson
Minimal Residual Disease Assessed by Multiparameter Flow Cytometry in Multiple Myeloma: Impact on Outcome in the Medical Research Council Myeloma IX Study2013
Dr Sarah Fordham
Dr Victoria Forster
Professor Graham Jackson
Dr Simon Bomken
Dr James Allan
et al.
A functional variant in the core promoter of the CD95 cell death receptor gene predicts prognosis in acute promyelocytic leukemia2012
Professor Graham Jackson
A novel prognostic model in myeloma based on co-segregating adverse FISH lesions and the ISS: analysis of patients treated in the MRC Myeloma IX trial2012
Professor Graham Jackson
Professor Christine Harrison
Professor Simon Bailey
Burkitt's lymphoma2012
Professor Graham Jackson
Cyclophosphamide, thalidomide, and dexamethasone as induction therapy for newly diagnosed multiple myeloma patients destined for autologous stem-cell transplantation: MRC Myeloma IX randomized trial results2012
Professor Graham Jackson
Effects of induction and maintenance plus long-term bisphosphonates on bone disease in patients with multiple myeloma: the Medical Research Council Myeloma IX Trial2012
Dr Mario Abinun
Professor Graham Jackson
Haematopoietic stem cell transplantation (HSCT) in severe autoimmune diseases: analysis of UK outcomes from the British Society of Blood and Marrow Transplantation (BSBMT) data registry 1997-20092012
1234567891011121314151617